Skip to main content
SpringerLink
Log in

Is Obesity Worth Treating in the Elderly?

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Obesity is associated with a range of health problems and affects an increasing number of people. However, the body mass index (BMI) that is associated with minimum mortality increases with age. Therefore, when a bodyweight loss programme is initiated, the possible benefits should be carefully measured against the potential risks.

Elderly people with severe obesity, or those who have associated health risks such as hypertension or diabetes mellitus, are in greatest need of bodyweight control. The use of drugs may be advisable in some individuals, but the treatment duration should be short and administered under strict supervision.

Many studies have shown that habitual, moderate physical activity and dietary improvement (i.e. moderating fat intake, avoiding micronutrient deficiencies and increasing fibre consumption) can be useful in achieving bodyweight control in the elderly. These measures are especially effective in improving nutritional status and may therefore be recommended in elderly individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bidlack WR. Interrelationships of food, nutrition, diet and health: the National Association of State Universities and Land Grant Colleges White Paper. J Am Coll Nutr 1996; 15: 422–33

    CAS  PubMed  Google Scholar 

  2. Singh RB, Niaz MA, Ghosh S, et al. Epidemiological study of coronary artery disease and its risk factors in an elderly urban population of north India. J Am Coll Nutr 1995; 14: 628–34

    CAS  PubMed  Google Scholar 

  3. Seim HC, Holtmeier KB. Treatment of obesity in the elderly. Am Fam Physician 1993; 47: 1183–9

    CAS  PubMed  Google Scholar 

  4. Schlienger JL, Pradignac A, Grunenberger F. Nutrition of the elderly: a challenge between facts and needs. Horm Res 1995; 43: 46–51

    Article  CAS  PubMed  Google Scholar 

  5. Mennen LI, Witteman JC, Geleijnse JM, et al. Risk factors for cardiovascular diseases in the elderly: the ERGO study (Erasmus Rotterdam Health and the Elderly). Ned Tijdschr Geneeskd 1995; 139: 1983–8

    CAS  PubMed  Google Scholar 

  6. Gofin J, Abramson JH, Kark JD, et al. The prevalence of obesity and its changes over time in middle-aged and elderly men and women in Jerusalem. Int J Obes Relat Metab Disord 1996; 20: 260–6

    CAS  PubMed  Google Scholar 

  7. Carek PJ, Sherer JT, Carson DS. Management of obesity: medical treatment options. Am Fam Physician 1997; 55: 551–8, 561-2

    CAS  PubMed  Google Scholar 

  8. Elks ML. Appetite suppressants as adjuncts in the treatment of obesity. J Fam Pract 1996; 42: 287–92

    CAS  PubMed  Google Scholar 

  9. Oddis CV. New perspectives on osteoarthritis. Am J Med 1996; 100Suppl. 2A: 10S–5S

    Article  CAS  PubMed  Google Scholar 

  10. Ortega RM, Fernández-Azuela M, Encinas-Sotillos A, et al. Differences in diet and food habits between patients with gallstones and controls. J Am Coll Nutr 1997; 16: 88–95

    CAS  PubMed  Google Scholar 

  11. Pereira JL, Villamil F, Garcia Luna PP. Tratamiento farmacologico de la obesidad. In: Soriguer FJC, editor. La obesidad. Madrid: Diaz de Santos, 1994: 257–67

    Google Scholar 

  12. Wilhelmi G. Potentielle Einflusse der Nahrung samt Zusatzstoffen auf gesunde und arthrotische Gelenke: II Nahrungsquantitat, Zusatzstoffe, Kontaminationen. Z Rheumatol 1993; 52: 191–200

    CAS  PubMed  Google Scholar 

  13. Andres R, Elahi D, Tobin JD, et al. Impact of age on weight goals. Ann Intern Med 1985; 103: 1030–3

    CAS  PubMed  Google Scholar 

  14. Borrelli R, Isernia C, Di Biase G, et al. Mortality rate, causes and predictive factors of death in severely obese patients. Int J Vitam Nutr Res 1988; 58: 343–50

    CAS  PubMed  Google Scholar 

  15. Haruyama M. Relationships among obesity, atherosclerotic disorders, and longevity in the elderly: an autopsy study. Nippon Ika Daigaku Zasshi 1995; 62: 231–40

    CAS  PubMed  Google Scholar 

  16. Kao CH, Chen CC, Wang SJ. Normal data for lumbar spine bone mineral content in healthy elderly Chinese: influences of sex, age, obesity and ethnicity. Nucl Med Commun 1994; 15: 916–20

    Article  CAS  PubMed  Google Scholar 

  17. Cawthorne MA, Smith SA, Young P. Effect of thermogenic drugs on insulin sensitivity and glucose utilization by brown adipose tissue. In: Berry EM, Blondheim SH, Elinhou HE, et al., editors. Recent advances in obesity research: V. London: John Libbey, 1987: 312–8

    Google Scholar 

  18. Talley NJ, O’Keefe EA, Zinsmeister AR, et al. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992; 102: 895–901

    CAS  PubMed  Google Scholar 

  19. Leeds AR. Dietary fibre: mechanisms of action. Int J Obes 1987; 11Suppl. I: 27–31

    Google Scholar 

  20. Mooradian AD. Drug therapy of non-insulin-dependent diabetes mellitus in the elderly. Drugs 1996; 51: 931–41

    Article  CAS  PubMed  Google Scholar 

  21. Lee AJ. Metformin in noninsulin-dependent diabetes mellitus. Pharmacotherapy 1996; 16: 327–51

    CAS  PubMed  Google Scholar 

  22. Marks SJ, Moore NR, Clark ML, et al. Reduction of visceral adipose tissue and improvement of metabolic indices: effect of dexfenfluramine in NIDDM. Obes Res 1996; 4: 1–7

    CAS  PubMed  Google Scholar 

  23. Ditschuneit HH, Flechtner Mors M, Adler G. The effects of dexfenfluramine on weight loss and cardiovascular risk factors in female patients with upper and lower body obesity. J Cardiovasc Risk 1996; 3: 397–403

    Article  CAS  PubMed  Google Scholar 

  24. Connolly VM, Gallagher A, Kesson CM. A study of fluoxetine in obese elderly patients with type 2 diabetes. Diabet Med 1995; 12: 416–8

    Article  CAS  PubMed  Google Scholar 

  25. Pedrinola F, Sztejnsznajd C, Lima N, et al. The addition of dexfenfluramine to fluoxetine in the treatment of obesity: a randomized clinical trial. Obes Res 1996; 4: 549–54

    CAS  PubMed  Google Scholar 

  26. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997; 337: 581–8

    Article  CAS  PubMed  Google Scholar 

  27. Miller WC, Lindeman AK, Wallace JP, et al. Diet composition, energy intake, and exercise in relation to body fat content in men and women. Am J Clin Nutr 1990; 52: 426–30

    CAS  PubMed  Google Scholar 

  28. Ortega RM, Redondo MR, Lopez-Sobaler AM, et al. Associations between obesity, breakfast-time food habits and intake of energy and nutrients in a group of elderly Madrid residents. J Am Coll Nutr 1996; 15: 65–72

    CAS  PubMed  Google Scholar 

  29. Ortega RM, Redondo MR, Zamora MJ, et al. Eating behavior and energy and nutrient intake in overweight/obese and normal-weight Spanish elderly. Ann Nutr Metab 1995; 39: 371–8

    Article  CAS  PubMed  Google Scholar 

  30. Ortega RM, Redondo MR, Zamora MJ, et al. Energy balance and caloric profile in the elderly obese or in those with overweight compared to those of normal weight. Med Clin (Barc) 1995; 104: 526–9

    CAS  Google Scholar 

  31. Johnson RK, Goran MI, Poehlman ET. Correlates of over- and underreporting of energy intake in healthy older men and women. Am J Clin Nutr 1994; 59: 1286–90

    CAS  PubMed  Google Scholar 

  32. Blundell JE, Halford JCG. Pharmacological aspects of obesity treatment: towards the 21st century. Int J Obes 1995; 19Suppl. 3: S51–5

    CAS  Google Scholar 

  33. Buchowski MS, Sun M. Nutrition in minority elders: current problems and future directions. J Health Care Poor Underserved 1996; 7: 184–209

    Article  CAS  PubMed  Google Scholar 

  34. Flynn MA, Irvin W, Krause G. The effect of folate and cobalamin on osteoarthritic hands. J Am Coll Nutr 1994; 13: 351–6

    CAS  PubMed  Google Scholar 

  35. Poehlman ET, Toth MJ, Fonong T. Exercise, substrate utilization and energy requirements in the elderly. Int J Obes Relat Metab Disord 1995; 19Suppl. 4: S93–6

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nutrition, Faculty of Pharmacy, Universidad Complutense, E-28040, Madrid, Spain

    Rosa María Ortega

  2. Technical Instrumentation Laboratory, Faculty of Pharmacy, Universidad Complutense, Madrid, Spain

    Pedro Andrés

Authors
  1. Rosa María Ortega
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pedro Andrés
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ortega, R.M., Andrés, P. Is Obesity Worth Treating in the Elderly?. Drugs & Aging 12, 97–101 (1998). https://doi.org/10.2165/00002512-199812020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199812020-00002

Keywords

Search

Navigation